Literature DB >> 20445208

A long story made too short: surrogate variables and the communication of HPV vaccine trial results.

Ansgar Gerhardus, Oliver Razum.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20445208     DOI: 10.1136/jech.2009.090183

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  6 in total

1.  Who profits from uncritical acceptance of biased estimates of vaccine efficacy and safety?

Authors:  Lucija Tomljenovic; Christopher A Shaw
Journal:  Am J Public Health       Date:  2012-07-19       Impact factor: 9.308

2.  An Ethical Justification for Expanding the Notion of Effectiveness in Vaccine Post-Market Monitoring: Insights from the HPV Vaccine in Canada.

Authors:  Ana Komparic; Maxwell J Smith; Alison Thompson
Journal:  Public Health Ethics       Date:  2015-01-29       Impact factor: 1.940

3.  Application of real-time global media monitoring and 'derived questions' for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines.

Authors:  Priya Bahri; Julianna Fogd; Daniel Morales; Xavier Kurz
Journal:  BMC Med       Date:  2017-05-02       Impact factor: 8.775

Review 4.  Listen to the public and fulfil their information interests - translating vaccine communication research findings into guidance for regulators.

Authors:  Priya Bahri; Mireia Castillon Melero
Journal:  Br J Clin Pharmacol       Date:  2018-05-31       Impact factor: 4.335

5.  HPV vaccines and cancer prevention, science versus activism.

Authors:  Lucija Tomljenovic; Judy Wilyman; Eva Vanamee; Toni Bark; Christopher A Shaw
Journal:  Infect Agent Cancer       Date:  2013-02-01       Impact factor: 2.965

6.  A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.

Authors:  Anna Melissa Guerrero; Anne Julienne Genuino; Melanie Santillan; Naiyana Praditsitthikorn; Varit Chantarastapornchit; Yot Teerawattananon; Marissa Alejandria; Jean Anne Toral
Journal:  BMC Public Health       Date:  2015-07-30       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.